Greenwich Lifesciences Inc (GLSI) stock has gained 14.72% over the past week and gets a Neutral rating from InvestorsObserver's Sentiment Indicator.
What is Stock Sentiment?
In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.
Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive.
InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend.
Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .
What's Happening With GLSI Stock Today?
Greenwich Lifesciences Inc (GLSI) stock is trading at $38.18 as of 1:42 PM on Monday, Apr 26, a rise of $1.75, or 4.8% from the previous closing price of $36.43. The stock has traded between $35.33 and $38.99 so far today. Volume today is light. So far 163,248 shares have traded compared to average volume of 826,399 shares.
To screen for more stocks like Greenwich Lifesciences Inc click here.
More About Greenwich Lifesciences Inc
Greenwich LifeSciences Inc is a clinical stage bio-pharmaceutical company focused on the development of an immunotherapy to prevent breast cancer recurrences in patients.
Click Here to get the full Stock Score Report on Greenwich Lifesciences Inc (GLSI) Stock.
